1-2 of 2
Elisabeth Bellard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation

In Special Collection:
Innate Lymphoid Cells 2024 , JEM Mucosal Immunology 2024
Pauline Schmitt, Anais Duval, Mylène Camus, Emma Lefrançais, Stéphane Roga, Cécile Dedieu, Nathalie Ortega, Elisabeth Bellard, Emilie Mirey, Emmanuelle Mouton-Barbosa, Odile Burlet-Schiltz, Anne Gonzalez-de-Peredo, Corinne Cayrol, Jean-Philippe Girard
Journal: Journal of Experimental Medicine
J Exp Med (2024) 221 (6): e20231236.
https://doi.org/10.1084/jem.20231236
Published: 10 April 2024
View article titled, TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
Open the PDF for TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation in another window
Includes: Supplementary data
Journal Articles

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor

Sophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, Julie Tabiasco, Alexandra Provost, Muriel Golzio, Muhammad Zaeem Noman, Jérôme Giustiniani, Elisabeth Bellard, Stéphanie Brayer, Maryse Aguerre-Girr, Fabienne Meggetto, Sylvie Giuriato, François Malecaze, Stéphane Galiacy, Jean-Philippe Jaïs, Olivier Chose, Jean Kadouche, Salem Chouaib, Justin Teissié, Marc Abitbol, Armand Bensussan, Philippe Le Bouteiller
Journal: Journal of Experimental Medicine
J Exp Med (2011) 208 (5): 973–986.
https://doi.org/10.1084/jem.20100810
Published: 11 April 2011
View article titled, A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Open the PDF for A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor in another window
Includes: Supplementary data